PEANUT ALLERGY
Clinical trials for PEANUT ALLERGY explained in plain language.
Never miss a new study
Get alerted when new PEANUT ALLERGY trials appear
Sign up with your email to follow new studies for PEANUT ALLERGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a shot make peanut allergy treatment safer and more effective?
Disease control Not yet recruitingThis study tests whether adding tezepelumab (an injected drug) to peanut oral immunotherapy (OIT) helps people with peanut allergy tolerate more peanut without symptoms. About 62 people aged 12–55 who react to tiny amounts of peanut will receive either tezepelumab or placebo for …
Matched conditions: PEANUT ALLERGY
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Could Super-Heated peanuts make allergy therapy safer?
Disease control Not yet recruitingThis study tests two forms of peanut oral immunotherapy (OIT) in 57 people aged 4 to 30 with peanut allergy. One group gets standard peanuts, the other gets autoclaved peanuts (heated under high pressure to change their proteins). The goal is to see which approach is safer and be…
Matched conditions: PEANUT ALLERGY
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 12, 2026 13:41 UTC